A smart genome scan could help scratch the itch for new antifungal drugs

Coloured Scanning Electron Micrograph of the fungus Candida albicans

Using an algorithm they developed, researchers identified a fungus that makes a chemical weapon against infectious fungi such as Candida albicans (pictured). Credit: Eye of Science/Science Photo Library


A smart genome scan could help scratch the itch for new antifungal drugs

Genome mining uncovers how a fungus makes a chemical agent against others of its kind.

The key to creating new antifungal drugs might be hiding in the genomes of fungi that need to protect themselves from their own chemical weapons.

To defend itself against other fungi, Penicillium restrictum makes a molecule called restricticin, which blocks a crucial fungal enzyme. Shutting down the enzyme can curb the growth of fungi, such as Candida albicans, that infect humans.

How P. restrictum makes restricticin has been unknown, but Yi Tang at the University of California, Los Angeles, and his colleagues realized that any fungus that makes restricticin would also need to protect itself from its own poison. They suspected that the fungal genes that encode restricticin might sit close to genes for a restricticin-resistant version of its target enzyme.

The researchers built a genome-mining algorithm to look for genes encoding a resistant enzyme near clusters of genes that could potentially make restricticin. The algorithm led to the discovery of the biosynthetic pathway for restricticin — and showed that the compound is also produced by other species of fungus. The authors hope that their genome-mining method will lead to the identification of other naturally occurring antifungal substances.

Products You May Like

Articles You May Like

Sugar-Coated Brain Implants: Scientists Find Sweet Solution to a Hard Problem
NASA’s Voyager 1 Space Probe Detects ‘Persistent Hum’ 14 Billion Miles From Earth
Why everyone from Elon Musk to Janet Yellen is worried about bitcoin’s energy usage
Payment tech company Marqeta files for IPO as value tops $16 billion on private markets
Colonial Pipeline cyberattack is no cause for panic – here’s why

Leave a Reply

Your email address will not be published. Required fields are marked *